Antonio Lanzavecchia

from Wikipedia, the free encyclopedia
Antonio Lanzavecchia

Antonio Lanzavecchia (* 1951 in Italy ) is an immunologist . He is the founding director of the Istituto di Ricerca in Biomedicina in Bellinzona , Switzerland .

Live and act

Antonio Lanzavecchia studied medicine at the University of Pavia and trained in paediatrics and infectious diseases . From 1993 he worked at the Basel Institute for Immunology and in 2000 moved to the Istituto di Ricerca in Biomedicina Bellinzona as founding director . He taught immunology in Genoa and Siena . Since 2009 he has also held a full professorship for immunology at ETH Zurich , where he retired at the beginning of 2017.

Lanzavecchia has published on numerous aspects of immunology. His research interests include antigen processing and -presentation , biology of dendritic cells , activation of lymphocytes and their migration as well as the memory of T cells and B cells .

Together with Rino Rappuoli , Stephan Becker and colleagues he developed a variant of the hybridoma technique using the Epstein-Barr virus for immortalization of B-cells . The method has been successfully used to produce monoclonal antibodies against SARS-CoV , H5N1 , HCMV , Dengue , Malaria and HIV-1 .

Lanzavecchia is one of the most influential and most cited immunologists. It has (as of January 2018) an h-index of 127.

Antonio Lanzavecchia has been a member of the European Molecular Biology Organization (EMBO) since 1988 , and was also awarded the EMBO Gold Medal in 1988. In 1999 he received the Cloëtta Prize and in 2014 he was nominated for the SwissAward . In 2016 he became a member of the National Academy of Sciences , for 2017 he was awarded the Robert Koch Prize and for 2018 the Prix ​​Louis-Jeantet .

Web links

Individual evidence

  1. ↑ Nine professors appointed. In: ethz.ch. September 29, 2016. Retrieved July 2, 2017 .
  2. Jump up ↑ E. Traggiai, S. Becker, K. Subbarao, L. Kolesnikova, Y. Uematsu, MR Gismondo, BR Murphy, R. Rappuoli, A. Lanzavecchia: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. In: Nature Medicine . Volume 10, Number 8, August 2004, ISSN  1078-8956 , pp. 871-875, doi: 10.1038 / nm1080 , PMID 15247913 .
  3. ^ Antonio Lanzavecchia - Google Scholar Citations. In: scholar.google.com. Retrieved January 18, 2018 .
  4. ↑ Antonio Lanzavecchia. In: people.embo.org. Retrieved July 2, 2017 .
  5. ↑ A. Lanzavecchia: Clonal sketches of the immune response. In: The EMBO journal. Volume 7, Number 10, October 1988, pp. 2945-2951, PMID 3053159 , PMC 454675 (free full text) (review).
  6. ^ Cloëtta Prize - Max Cloëtta Foundation. In: cloetta-foundation.ch. Retrieved May 16, 2018 .
  7. ↑ Manuela Donati, Markus Krucker: “SwissAward”: an overview of the winners. In: srf.ch. April 21, 2016. Retrieved July 2, 2017 .
  8. ↑ Antonio Lanzavecchia. In: nasonline.org. Retrieved July 2, 2017 .
  9. ^ Robert Koch Foundation - Antonio Lanzavecchia. In: robert-koch-stiftung.de. Retrieved July 2, 2017 .
personal data
SURNAME Lanzavecchia, Antonio
BRIEF DESCRIPTION Italian immunologist
DATE OF BIRTH 1951
PLACE OF BIRTH Italy